The global medical billing solution market is valued at US$3.8 billion in 2025 and is forecast to reach US$6.1 billion by 2031, a compound annual growth rate (CAGR) of 8.3% over 2025-2031. The market is measured as vendor revenue from software and related hardware used to create and submit claims, validate coding, post payments and manage denials, in US dollars. Outsourced billing services are excluded. The 2025 base is the median of three published software-only sizes (US$2.4, 3.8 and 6.5 billion); the figures are model estimates, not audited totals.
The report segments the market by four types and four applications. Cloud-Based Software is the largest type and Hospitals and Health Systems is the largest application. North America is the largest region. Cloud-based software is the fastest-growing type at 11.0% a year, while on-premise software grows 2.0% a year.
Scope of the Global Medical Billing Solution Market Strategic Research Report
This report covers market value (US$ million) for 2022-2031, with 2025 as the base year and 2026-2031 as the forecast period. It analyses four types, four applications, five regions and named countries, and profiles 18 companies. No volume series is published because no source gives licences, seats or claims volume for this scope.
Segment by Type
Segment by Application
Who Can Use This Report?
1. Executive Summary
1.1 Market Definition and Scale
1.2 Principal Growth Drivers
1.3 Segmentation Highlights
1.4 Regional and Country Highlights
1.5 Competitive Structure and Notable Corporate Activity
1.6 Principal Risks and Restraints
1.7 Outlook
2. Industry Overview & Forecast
2.1 Market Definition and Scope
2.2 Market Size and Historical Performance
2.3 Forecast and Growth Logic
2.4 Volume Analysis
2.5 Value Chain and Pricing Dynamics
3. Market Segmentation by Type
3.1 Overview of the Type Segmentation Framework
3.1.1 Cloud-Based Software
3.1.2 On-Premise Software
3.1.3 Hybrid Software
3.1.4 Hardware and Devices
3.1.5 Comparative Analysis: Mix Shift Across the Forecast Period
4. Market Segmentation by Application
4.1 Overview of the Application Framework
4.1.1 Hospitals and Health Systems
4.1.2 Clinics and Physician Practices
4.1.3 Ambulatory and Diagnostic Centers
4.1.4 Payers and Others
4.1.5 Comparative Segment Analysis
5. Regional Market Forecast
5.1 North America
5.1.1 Regional Overview
5.1.2 Key Growth Drivers
5.1.3 Regulatory & Infrastructure Landscape
5.1.4 Country-Level Analysis
5.1.5 Market Forecast 2025–2031
5.2 Europe
5.2.1 Regional Overview
5.2.2 Key Growth Drivers
5.2.3 Regulatory & Infrastructure Landscape
5.2.4 Country-Level Analysis
5.2.5 Market Forecast 2025–2031
5.3 Asia Pacific
5.3.1 Regional Overview
5.3.2 Key Growth Drivers
5.3.3 Regulatory & Infrastructure Landscape
5.3.4 Country-Level Analysis
5.3.5 Market Forecast 2025–2031
5.4 Latin America
5.4.1 Regional Overview
5.4.2 Key Growth Drivers
5.4.3 Regulatory & Infrastructure Landscape
5.4.4 Country-Level Analysis
5.4.5 Market Forecast 2025–2031
5.5 Middle East and Africa
5.5.1 Regional Overview
5.5.2 Key Growth Drivers
5.5.3 Regulatory & Infrastructure Landscape
5.5.4 Country-Level Analysis
5.5.5 Market Forecast 2025–2031
6. Country-Level Market Forecast
6.1 North America
6.1.1 United States
6.1.2 Canada
6.1.3 Rest of North America
6.2 Europe
6.2.1 Germany
6.2.2 United Kingdom
6.2.3 France
6.2.4 Italy
6.2.5 Spain
6.2.6 Netherlands
6.2.7 Rest of Europe
6.3 Asia Pacific
6.3.1 China
6.3.2 Japan
6.3.3 India
6.3.4 South Korea
6.3.5 Australia
6.3.6 Rest of Asia Pacific
6.4 Latin America
6.4.1 Brazil
6.4.2 Mexico
6.4.3 Rest of Latin America
6.5 Middle East and Africa
6.5.1 Saudi Arabia
6.5.2 United Arab Emirates
6.5.3 South Africa
6.5.4 Egypt
6.5.5 Rest of Middle East and Africa
7. Growth Drivers & Inhibitors
7.1 Market Growth Drivers
7.2 Market Restraints and Inhibitors
7.3 Impact Assessment Summary
7.4 Integrated Assessment
8. Key Company Profiles
8.1 Epic Systems
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2025–2031)
8.2 Oracle Health (including Cerner)
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2025–2031)
8.3 athenahealth
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2025–2031)
8.4 Optum
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2025–2031)
8.5 Waystar
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2025–2031)
8.6 GE HealthCare
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2025–2031)
8.7 NextGen Healthcare
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2025–2031)
8.8 Veradigm
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2025–2031)
8.9 eClinicalWorks
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2025–2031)
8.10 CareCloud
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2025–2031)
8.11 AdvancedMD
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2025–2031)
8.12 Tebra (Kareo)
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2025–2031)
8.13 CompuGroup Medical
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2025–2031)
8.14 Phreesia
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2025–2031)
8.15 TruBridge
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2025–2031)
8.16 Cegedim
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2025–2031)
8.17 R1 RCM
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2025–2031)
8.18 RXNT
8.18.1 Company Overview
8.18.2 Key Products & Segments
8.18.3 Financial Performance (2023–2025)
8.18.4 Business Strategy
8.18.5 SWOT Analysis
8.18.6 Strategic Implications (2025–2031)
9. Competitive Landscape
9.1 Competitive Landscape Overview
9.1.1 Market Structure and Profiled Participants
9.1.2 Verified Company Reference Data
9.1.3 Why Concentration Cannot Be Measured
9.1.4 Scale Asymmetry and Competitive Groupings
9.1.5 Overall Competitive Intensity Assessment
9.2 Competitive Intensity Assessment
9.2.1 The Structural Character of Competition
9.2.2 Scale Dispersion Among Profiled Vendors
9.2.3 Capacity Relative to Demand
9.2.4 Pricing Environment
9.2.5 Barriers to Entry and Exit
9.3 Key Player Strategies & Positioning
9.3.1 Strategic Group Map Narrative
9.3.2 Selected Profiled Vendor Revenue Summary (Most Recent Reported Year)
9.3.3 Differentiation Strategies Across Major Players
9.3.4 Geographic Strongholds
9.3.5 M&A and Partnership Activity (2022–Present)
9.3.6 R&D and Technology Investment Trends
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats and New Market Entrants
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations for 2026–2031
10. Porter's Five Forces Analysis
10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry
11. PESTLE Analysis
11.1.1 Political
11.1.2 Economic
11.1.3 Sociocultural
11.1.4 Technological
11.1.5 Legal
11.1.6 Environmental
11.1.7 PESTLE Summary Assessment Table
12. SWOT Analysis
12.1 Industry SWOT Analysis
12.1.1 Detailed Analysis
12.1.1.1 Strengths
12.1.1.2 Weaknesses
12.1.1.3 Opportunities
12.1.1.4 Threats
12.1.2 Strategic Implications
13. Future Trends & Outlook
13.1 Preamble: Analytical Framing
13.2 Trend Analysis
13.2.1 Accelerating Migration to Cloud-Based Delivery Models
13.2.2 Claims Denial Volumes Driving Demand for Scrubbing and Denial Management Modules
13.2.3 Inorganic Growth and Platform Consolidation Reshaping Competitive Structure
13.2.4 Healthcare Spending Growth Expanding the Addressable Claims Universe
13.2.5 Flat to Declining Revenue at European Software Vendors Signalling Regional Differentiation
13.2.6 Independent Practice Segment Under Revenue Pressure Creating Software Spending Tension
13.2.7 Broader Payments Platform Vision Expanding Market Scope Beyond Core Billing
13.2.8 Asia Pacific Positioned as the Fastest-Growing Regional Market
13.3 Summary Trend Assessment Table
13.4 Forward Outlook: 2026–2031
List of Exhibits
Exhibit 2.1: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.2: Forecast of Global Market (in USD Bn)
Exhibit 2.3: Forecast of North America (in USD Bn)
Exhibit 2.4: Forecast of Europe (in USD Bn)
Exhibit 2.5: Forecast of Asia Pacific (in USD Bn)
Exhibit 2.6: Forecast of Latin America (in USD Bn)
Exhibit 2.7: Forecast of Middle East and Africa (in USD Bn)
Exhibit 3.8: Forecast of Cloud-Based Software (in USD Bn)
Exhibit 3.9: Forecast of On-Premise Software (in USD Bn)
Exhibit 3.10: Forecast of Hybrid Software (in USD Bn)
Exhibit 3.11: Forecast of Hardware and Devices (in USD Bn)
Exhibit 4.12: Forecast of Hospitals and Health Systems (in USD Bn)
Exhibit 4.13: Forecast of Clinics and Physician Practices (in USD Bn)
Exhibit 4.14: Forecast of Ambulatory and Diagnostic Centers (in USD Bn)
Exhibit 4.15: Forecast of Payers and Others (in USD Bn)
Exhibit 6.16: Forecast of North America (in USD Bn)
Exhibit 6.17: Forecast of United States (in USD Bn)
Exhibit 6.18: Forecast of Canada (in USD Bn)
Exhibit 6.19: Forecast of Rest of North America (in USD Bn)
Exhibit 6.20: Forecast of Europe (in USD Bn)
Exhibit 6.21: Forecast of Germany (in USD Bn)
Exhibit 6.22: Forecast of United Kingdom (in USD Bn)
Exhibit 6.23: Forecast of France (in USD Bn)
Exhibit 6.24: Forecast of Italy (in USD Bn)
Exhibit 6.25: Forecast of Spain (in USD Bn)
Exhibit 6.26: Forecast of Netherlands (in USD Bn)
Exhibit 6.27: Forecast of Rest of Europe (in USD Bn)
Exhibit 6.28: Forecast of Asia Pacific (in USD Bn)
Exhibit 6.29: Forecast of China (in USD Bn)
Exhibit 6.30: Forecast of Japan (in USD Bn)
Exhibit 6.31: Forecast of India (in USD Bn)
Exhibit 6.32: Forecast of South Korea (in USD Bn)
Exhibit 6.33: Forecast of Australia (in USD Bn)
Exhibit 6.34: Forecast of Rest of Asia Pacific (in USD Bn)
Exhibit 6.35: Forecast of Latin America (in USD Bn)
Exhibit 6.36: Forecast of Brazil (in USD Bn)
Exhibit 6.37: Forecast of Mexico (in USD Bn)
Exhibit 6.38: Forecast of Rest of Latin America (in USD Bn)
Exhibit 6.39: Forecast of Middle East and Africa (in USD Bn)
Exhibit 6.40: Forecast of Saudi Arabia (in USD Bn)
Exhibit 6.41: Forecast of United Arab Emirates (in USD Bn)
Exhibit 6.42: Forecast of South Africa (in USD Bn)
Exhibit 6.43: Forecast of Egypt (in USD Bn)
Exhibit 6.44: Forecast of Rest of Middle East and Africa (in USD Bn)
*If Applicable.
NAVADHI is a market research company that helps global firms differentiate themselves, break market entry barriers, track their investments, develop business strategies and plan for future by providing actionable market research intelligence that helps them succeed.